Call (407) 512-8878 Home About Dr. Chantasi

Services

Pain Care Regenerative Pain Management Back & Neck Pain Joint Pain Tendon & Ligament Neuropathy Stem Cell Therapy Cost Regenerative Medicine Guide Hormone Therapy Weight Loss Botox & Neurotoxins Korean Beauty Orlando Korean Skin Care Concierge Services Memberships Join PrimeCellMed

More

Payment Plans Patient Blog Industry Insights PrimeCell Shop FAQ Request a Consultation
← Patient Blog

Patient Blog

How Do You Know If You’re a Good Candidate for Regenerative Medicine?

Physician reviewing a patient's musculoskeletal imaging and history during a regenerative medicine evaluation

There is no single test that confirms candidacy for regenerative medicine. It depends on a few things:

  • The specific condition.
  • How long it has been present.
  • What has already been tried.
  • What a physical exam shows.
  • What an imaging review shows.

People with chronic joint, tendon, or soft-tissue complaints are the ones most often considered. That means people who have not responded to standard, conservative care. Not everyone who asks is a reasonable fit (Buckles, 2019).

What This Means

Say you’ve had joint or tendon pain for months. Then “am I a candidate?” is really two questions. Does your condition fall into a group where regenerative approaches are even studied? And has a physician actually looked at your case?

A clinic that says yes to every caller before an exam isn’t practicing evidence-based medicine (Buckles, 2019). Candidacy is decided case by case, after a real evaluation. A phone screening or an online quiz cannot do it.

Candidacy

People most often considered reasonable candidates tend to have chronic tendon, ligament, or joint complaints. These include:

  • Tendon irritation.
  • Mild-to-moderate osteoarthritis.
  • Soft-tissue injuries.

These complaints haven’t fully responded to rest, physical therapy, or standard pain management. The person also isn’t ready for surgery, or isn’t interested in it (Buckles, 2019; Gupta et al., 2024).

People are generally not reasonable candidates if they have:

  • Active infection at the injection site.
  • Certain bleeding disorders, or blood thinners a physician has not cleared.
  • Pregnancy.
  • Active cancer in the area being evaluated.
  • Imaging or exam findings that point to a different problem. That problem may need medical attention first. Examples include a fracture, a severe structural tear, or an unrelated systemic illness.

A careful evaluation exists to catch these situations before any procedure is considered.

Clinical Evaluation

A real evaluation is not a sales pitch. It usually includes:

  • A detailed history. This covers how long the symptoms have been present. It also covers what has been tried, and what makes them better or worse.
  • A physical and musculoskeletal exam of the affected area.
  • Review of prior imaging, such as X-ray, MRI, or ultrasound. If none exists, a referral for imaging.
  • Ultrasound imaging, when appropriate, to look directly at the structure in question.
  • A talk about goals, such as pain relief, function, and activity tolerance. This covers what is realistic given your specific findings.

Florida law covers stem cell–based procedures that are not FDA-approved. Physicians who offer them must document this process formally, with a signed consent form. The form must describe:

  • The nature of the proposed procedure.
  • The fact that it has not been FDA-approved.
  • The anticipated results.
  • The known risks.
  • The available alternatives. This includes the option of no procedure at all (Fla. Stat. § 458.3245, 2025).

Available Options

Regenerative medicine is one option among several. It does not replace the full range of musculoskeletal care. What fits depends on the specific finding. Options commonly discussed include:

  • Physical therapy and planned changes in what you do.
  • Oral or topical anti-inflammatory medication.
  • Bracing, orthotics, or activity changes.
  • Corticosteroid or other guided injections.
  • Regenerative or orthobiologic procedures, where a physician determines they may be appropriate.
  • Surgical referral, when conservative and regenerative approaches aren’t a good match for the underlying problem.

Watch for a physician who offers only one option, no matter what the exam shows. That is a sign the evaluation wasn’t individualized.

Benefits, Limitations & Risks

Regenerative and orthobiologic procedures may offer a middle path. They are for people who haven’t responded to standard conservative care. They are also for people who aren’t ready for surgery, or don’t want it (Buckles, 2019). Some patients report improved comfort and function after a course of care.

They are not guaranteed to work, and they are not appropriate for every condition.

Most cellular and tissue-based regenerative products used outside an FDA-approved clinical trial are investigational. That means they have not been FDA-approved to diagnose, treat, cure, mitigate, or prevent any specific disease (U.S. Food and Drug Administration, 2021).

The FDA has documented real safety concerns tied to unapproved regenerative products (U.S. Food and Drug Administration, 2021). These concerns include:

  • Infection.
  • Unwanted tissue growth.
  • Reactions at the injection site.

In Florida, any physician who offers these procedures is legally required to disclose this in writing. That must happen before you proceed (Fla. Stat. . 458.3245, 2025).

What the Evidence Shows

Current research supports some regenerative approaches for specific musculoskeletal uses. This is true in particular for platelet-rich plasma. A body of controlled trials sits behind certain uses. Knee osteoarthritis and rotator cuff healing are two of them (Buckles, 2019).

A 2024 editorial reviewed recent research on regenerative biologics for musculoskeletal injuries. It found preliminary safety and potential benefit across several applications. It also noted that more randomized, controlled research is still needed. Broader conclusions cannot be drawn until then (Gupta et al., 2024).

The evidence does not yet establish:

  • A guaranteed outcome for any individual patient.
  • A standardized “best” protocol across products and providers.
  • Long-term data for every type of regenerative product on the market.

Research quality and study size vary a lot by product and condition. That is part of why an individualized evaluation should drive the decision. A product name should not (Gupta et al., 2024).

Recovery / Next Steps

Recovery expectations depend on which option is chosen and what is being addressed. So this is discussed individually after an evaluation. It is not promised in advance.

Regenerative procedures done in an outpatient setting are usually minimally invasive. They use local anesthesia. Most patients resume light activity within days. A structured return to full activity follows over the next weeks. Follow-up visits guide it (Mayo Clinic Orthopedics & Sports Medicine, n.d.).

Next steps after a consultation usually include:

  • A written care plan.
  • A discussion of realistic timelines specific to your findings.
  • Where regenerative products are involved, the signed disclosure and consent required under Florida law (Fla. Stat. § 458.3245, 2025).

Orlando Considerations

Florida has its own statute for stem cell procedures given by a physician. It covers the ones that fall outside FDA approval (Fla. Stat. § 458.3245, 2025). The law:

  • Limits these procedures to orthopedic, wound care, and pain management applications.
  • Requires the product to come from an FDA-registered facility. That facility must also be accredited by a recognized tissue-banking body.
  • Requires written advertising disclosure and signed patient consent before any procedure.

Are you comparing regenerative medicine practices in the Orlando area? Ask directly whether a practice and its product sourcing meet these state requirements. A practice following the law should be able to answer without hesitation.

FAQ

Does insurance cover regenerative medicine?

Most cash-pay regenerative and orthobiologic procedures are not covered by insurance. Many are considered investigational. Coverage varies by insurer and by the specific product or procedure. Ask directly during a consultation.

Can I get a regenerative procedure without trying anything else first?

Some physicians will discuss it directly for select conditions. But a responsible evaluation usually reviews what conservative care has or hasn’t already been tried. That context shapes who is a good fit.

Are regenerative medicine products the same everywhere?

No. Product type, source, and manufacturing standards vary a lot between clinics. Florida law covers any stem cell–based product used outside an FDA-approved trial. It must come from a facility that is FDA-registered and independently accredited (Fla. Stat. § 458.3245, 2025).

What disqualifies someone from regenerative medicine?

Common disqualifiers include:

  • Active infection at the treatment site.
  • Certain bleeding disorders.
  • Pregnancy.
  • Active cancer in the relevant area.
  • Findings on exam or imaging that point to a condition needing a different kind of care first.

How long does a consultation take?

Plan for a full evaluation visit rather than a quick screening. History, exam, and often an ultrasound or imaging review take real time to do properly.

Regenerative medicine procedures offered outside FDA-approved clinical trials are investigational. They are not FDA-approved to diagnose, treat, cure, mitigate, or prevent any specific disease.

Some patients report symptom improvement, and certain applications are supported by a growing body of research, but individual outcomes vary and are not guaranteed.

This article is for general education and is not a substitute for a personalized medical evaluation. Discuss your specific history, imaging, and goals with a licensed physician before making any decision. Medically reviewed by Kenny Chantasi, DO.

References

Buckles, S. (2019, May 17). Expert alert: Mayo Clinic orthopedist shares perspective on regenerative medicine. Mayo Clinic News Network.

Fla. Stat. § 458.3245. (2025). Stem cell therapy. The Florida Senate.

Gupta, A., Potty, A. G., & Maffulli, N. (2024). Editorial: Regenerative biologics for musculoskeletal injuries. Frontiers in Pain Research, 5, 1400548. https://doi.org/10.3389/fpain.2024.1400548

Mayo Clinic Orthopedics & Sports Medicine. (n.d.). Regenerative medicine. Mayo Clinic.

U.S. Food and Drug Administration. (2021, June 3). Important patient and consumer information about regenerative medicine therapies.

Last medically reviewed: August 19, 2026.

Have you had joint, tendon, or soft-tissue pain that hasn’t responded to standard care? A consultation is the only way to know where you actually stand. Schedule an evaluation with PrimeCell Regenerative. Bring prior imaging and records if you have them.

Ready when you are

Talk with a physician about your options

Have questions about whether this is right for you? Book a consultation with Dr. Chantasi, or call the clinic and we'll talk it through.

Orlando, FL · Mon–Fri 10am–6pm